Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 3,037 | 13,015 | 3,004 | 2,710 | 0 |
| Gross Profit | 3,037 | 13,015 | 3,004 | 2,710 | N/A |
| Operating Expenses | 28,725 | 32,110 | 31,144 | 22,626 | 19,788 |
| Operating Income | -25,688 | -19,095 | -28,140 | -19,916 | -19,788 |
| Other Income | 414 | 407 | 227 | 212 | 154 |
| Pre-tax Income | -25,274 | -18,688 | -27,913 | -19,704 | -19,634 |
| Net Income Continuous | -25,274 | -18,688 | -27,913 | -19,704 | -19,634 |
| Net Income | $-25,274 | $-18,688 | $-27,913 | $-19,704 | $-19,634 |
| EPS Basic Total Ops | -12.80 | -9.20 | -14.00 | -10.00 | 13.00 |
| EPS Basic Continuous Ops | -12.52 | -9.29 | -14.10 | -10.06 | 13.07 |
| EPS Diluted Total Ops | -12.80 | -9.20 | -14.00 | -10.00 | 13.00 |
| EPS Diluted Continuous Ops | -12.52 | -9.29 | -14.10 | -10.06 | 13.07 |
| EBITDA(a) | $-24,063 | $-17,939 | $-27,488 | $-19,530 | $-19,454 |